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Abstract: The retaining glycosyltransferase GalNAc-T2 is
a member of a large family of human polypeptide GalNAc-
transferases that is responsible for the post-translational
modification of many cell-surface proteins. By the use of
combined structural and computational approaches, we pro-
vide the first set of structural snapshots of the enzyme during
the catalytic cycle and combine these with quantum-mechanics/
molecular-mechanics (QM/MM) metadynamics to unravel the
catalytic mechanism of this retaining enzyme at the atomic-
electronic level of detail. Our study provides a detailed
structural rationale for an ordered bi–bi kinetic mechanism
and reveals critical aspects of substrate recognition, which
dictate the specificity for acceptor Thr versus Ser residues and
enforce a front-face SNi-type reaction in which the substrate N-
acetyl sugar substituent coordinates efficient glycosyl transfer.
O-GalNAc glycosylation[1] is by far the most complex and
differentially regulated type of protein glycosylation, and it
may also be the most abundant, with over 80% of all proteins
passing through the secretory pathway predicted to be O-
glycosylated.[2] One of the key enzyme isoforms that control
human protein O-glycosylation is polypeptide GalNAc-trans-
ferase 2 (GalNAc-T2). This enzyme is part of a large family of
retaining isoenzymes that transfer a GalNAc residue from
UDP-GalNAc to Ser/Thr side chains and thereby initiate
mucin-type or GalNAc-type protein O-glycosylation. How
GalNAc-Ts target specific sites on proteins and glycoproteins,
and how they catalyze O-GalNAc transfer is not understood.
Although the structures of several GalNAc-Ts have been
reported,[3] the lack of Michaelis complexes and ternary
product complexes has limited mechanistic insight into the
glycosyl-transfer reaction. Such information is required for
the rational design of inhibitors of these potential drug
targets.
Herein we describe the use of a combination of X-ray
crystallography and quantum-mechanics/molecular-mechan-
ics (QM/MM) metadynamics to unravel the catalytic mech-
anism of GalNAc-T2. The structures obtained provide the
first structural snapshots of the enzyme in complex with its
substrates and products during the catalytic cycle. The
findings reveal mobile loops that act to bind and release the
substrates and illuminate substrate acceptor preference for
threonine over serine. Furthermore, QM/MM metadynamics
simulations reveal a front-face reaction mechanism involving
a short-lived oxocarbenium-ion-like intermediate.
To obtain a Michaelis complex of GalNAc-T2, we
obtained crystals of GalNAc-T2 in complex with UDP-Mn2+
(UDP = uridine diphosphate) and soaked them first in
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a solution containing UDP-GalNAc and subsequently with
the EA2 acceptor peptide (sequence DSTTPAPTTK, in
which T is the predominant glycosylation site). The resulting
crystals diffracted fairly well, thus enabling the structure to be
solved at 2.45  (see Table S1 in the Supporting Information).
Six molecules of GalNAc-T2 are arranged in three independ-
ent dimers (see Figure S1 in the Supporting Information)
within the asymmetric unit. This arrangement is consistent
with a previous structure of GalNAc-T2 in complex with UDP
(PDB entry: 2FFV).[3b] The enzyme structures show the
typical GT-A fold located in the N-terminal region and lectin
domain located in the C-terminal region (see Figure S2 A).
They also feature a flexible loop that can adopt different
conformations (see Figure S2 A and discussion below).[3b] A
pre-Michaelis complex with UDP-GalNAc and the EA2
peptide, and a ternary complex with UDP and the reaction
product (the glycosylated EA2 peptide) were trapped in two
of the monomers (see Figure S2 B).
As an alternative strategy to obtain a Michaelis complex,
we were encouraged by structural studies of the inverting
enzyme OGT[4] to carry out a chemoenzymatic synthesis of
UDP-5SGalNAc[5] (Figure S3). The formation of glycosylated
peptides was assessed by mass spectrometry (see the Sup-
porting Information). As expected, UDP-5SGalNAc turned
out to be a slower substrate than UDP-GalNAc (the specific
activity with 2 mm UDP-GalNAc and 0.2 mm ApoCIII
peptide was approximately 15-fold higher than the activity
with UDP-5SGalNAc; see Figure S4). We also synthesized
truncated incompetent EA2 peptides in which the acceptor
Thr7 in EA2 was replaced with Cys or Ala (peptide sequences
STCPA and STAPA, hereafter named mEA2 peptides). We
performed cocrystallization experiments with UDP-5SGal-
NAc both alone and in combination with EA2 and mEA2
peptides; however, in all cases, we observed only UDP in the
active site. Therefore, we conducted soaking experiments (see
the Supporting Information) on the basis of the idea that this
more rapid process might enable trapping of the complex
before catalysis had occurred. Notably, we obtained data at
2.20 and 2.85  (see Table S1) that revealed four different
complexes within different monomeric units (see Table S2).
These monomeric units included the first Michaelis complex
structure of GalNAc-T2, containing UDP-5SGalNAc with
the mEA2 peptide STCPA (Figure 1), a binary complex
containing UDP-5SGalNAc alone, a ternary complex con-
taining UDP and mEA2, and a binary complex with UDP
alone (see Figure S2 D). Interestingly, 5SGalNAc was also
bound to the lectin domain in some monomers (see Fig-
ure S2E), thus suggesting that hydrolysis of UDP-5SGalNAc
took place during the relatively long soaking period. Unlike
GalNAc-T10, in which the sugar moiety is located in the b site
of the lectin domain,[3a] 5SGalNAc is located in the a site, and
is tethered by Asp458, Asn479, Tyr471, and His474 in
GalNAc-T2 (see Figure S2 E). This structure explains why
Asp458 (the only amino acid that establishes two hydrogen
bonds with the sugar moiety) is important for GalNAc–
peptide substrate specificity and consequently in tuning the
acceptor specificities to define the glycosylation profiles of
these enzymes.[6]
The enzyme active site shows the typical DxH motif
(Asp224-Ser225-His226), which, together with His359, coor-
dinates the manganese atom[3b] in all complexes characterized
(Figure 1; see also Figure S5). Specificity for the GalNAc
moiety of the donor substrate is defined by several hydrogen
bonds with Asp224, Trp331, Gly332, Arg208, Glu334, and
Gly308 (see Figure S5). UDP-5SGalNAc overlays well with
UDP-GalNAc in all ternary complexes, except the product
complex, for which a small displacement of the GalNAc
moiety is observed (see Figure S5D). The methyl group of the
acceptor Thr residue is embedded within a hydrophobic
pocket formed by Phe280, Trp282, Phe361, and Ala307 (see
Figure S5) in both the Michaelis and product complexes. This
interaction would be expected to increase the affinity of the
enzyme for the acceptor Thr and could explain the preference
of GalNAc-T2 for Thr residues.
The NH group of the acetamide moiety and the Trp331
side chain establish hydrogen bonds with a b-phosphate
oxygen atom in all ternary complexes (see Figure S5), thus
suggesting that these interactions may help define donor
substrate specificity and may also facilitate departure. Nota-
bly, the hydroxy oxygen atom of the acceptor Thr is quite
close to the anomeric carbon atom of the GalNAc moiety in
both the pre-Michaelis and the Michaelis complex (O···C1 =
3.8 and 2.5 , respectively; see Figure S5 A,B). Furthermore,
the Thr oxygen atom of the Michaelis complex is close to two
of the phosphate oxygen atoms (2.7 and 3.5 ), and there is
no obvious enzyme residue that could serve as a nucleophile
on the other face of the pyranose ring. All these features are
most consistent with a front-face type of reaction, in which the
phosphate leaving group accepts a proton from the nucleo-
philic Thr hydroxy group.
As mentioned above, an interesting and intriguing aspect
of GalNAc-T2 is the presence of a flexible loop that interacts
with the nucleotide-binding site (see Figure S2).[3b, 7] This loop,
formed by residues Arg362 to Ser373, was previously found to
adopt either a closed conformation (see PDB entry 2FFU in
Figure S6) to form a lid over UDP, or an open conformation in
which the loop folds back to expose UDP to bulk solvent[3b]
(see PDB entry 2FFV in Figure 2 A and Figure S6). The open
conformation was proposed to facilitate UDP release follow-
ing catalysis. By taking advantage of the catalytic competence
of our crystals, we can conclude that the flexible loop is in
a closed conformation when UDP-GalNAc (or UDP-5SGal-
Figure 1. Michaelis complex of GalNAc-T2. Electron-density maps are
Fo–Fc syntheses contoured at 2.0 s for the ligands and 2Fo–Fc
syntheses contoured at 1.0 s for the residues Asp224, His226, and
His359 (see Figure S2D for a color stereoview).
NAc) is bound within the active site, regardless of whether or
not the peptide is present (Figure 2A; see also Figure S6).
Unlike the structures with the sugar nucleotides, our non-
productive ternary complexes with UDP and mEA2 exhibit
a mixture of loop conformations (semi-open/closed) that
manifests as disorder during analysis of the density maps
(Figure 2A; see also Figure S6), thus suggesting that the
presence of the GalNAc moiety is important to keep the loop
in the closed conformation. These data are most consistent
with the opening of the active site, as the loop moves from
closed to open to facilitate the release of UDP at the end of
the catalytic cycle (Figure 2A). The corollary, which would be
the near microscopic reverse, is that the loop must initially be
open to bind UDP-GalNAc. Therefore, we conclude that the
closed conformation sets the enzyme in a catalytically com-
petent state, whereas the open conformation inactivates the
enzyme, although it enables reversible binding of the nucleo-
tide sugar.
The different loop conformations observed in our struc-
tures (see Table S2) correlate with two different Trp331
rotameric side-chain positions (see Figure S6 B). When the
loop is in the closed conformation, Trp331 is tethered by
stacking interactions with the GalNAc moiety of UDP-
GalNAc, His365, and Phe369. These interactions contribute
to keeping the flexible loop closed, thus facilitating further
interactions between Tyr367 and the a-phosphate oxygen
atom (see Figure S6 B). When GalNAc is not present,
however, Trp331 can move to a solvent-exposed position,
and the flexible loop switches to the open conformation, thus
enabling the release of UDP. Overall, our structural data
suggest an ordered bi–bi kinetic mechanism for GalNAc-T2
(Figure 2B), as demonstrated for OGT.[4b] This mechanism
contrasts with the random sequential mechanism previously
proposed for a bovine GalNAc-T in which either the sugar
nucleotide or the peptide may bind to the protein in a random
manner.[8]
To summarize, within the resting enzyme, the mobile loop
initially adopts both open and closed conformations until
UDP-GalNAc-Mn+2 binds, which causes Trp331 to stack
against the sugar and drives the loop to adopt the closed
conformation (Figure 2B). A peptide substrate then binds to
the enzyme. Subsequently, interactions between the enzyme,
UDP-GalNAc, and the peptide substrate enable catalysis to
take place, with the active site shielded from water. Following
glycosyl transfer, the glycopeptide product departs. At this
stage, Trp331 is no longer held in place, and the flexible loop
regains mobility between closed and open states, thus
permitting the UDP to be released and thereby completing
the catalytic cycle. Our proposed mechanism is consistent
with a previous experiment in which GalNAc-T2 was purified
by using a Muc2 peptide–Sepharose column. The enzyme
could only bind in the presence of UDP, and it was only
efficiently released upon the removal of UDP.[9]
Although the above structural insight shows the kinetic
mechanism and specific interactions within the enzyme active
site, it cannot define the precise reaction coordinate and
thereby distinguish between mechanistic variations.[10] We
therefore performed QM/MM simulations by using the
metadynamics approach to define precise details of the
glycosyl-transfer reaction for GalNAc-T2 in atomic detail
and obtain the free-energy landscape along the reaction
coordinate to distinguish between mechanistic variations.[10]
The ternary product complex was considered as a starting
point (see Figure S7). A combination of classical and QM/
MM molecular dynamics was used to equilibrate the enzyme
complex, without any restraint (see details in the Supporting
Information). Afterwards, the chemical reaction was acti-
vated by metadynamics[11] by using three collective variables
corresponding to the main covalent bonds undergoing
cleavage and formation (see Figure S8). The first collective
variable (C1–OThr distance) measures the formation/cleavage
of the glycosidic bond, whereas the second (C1–OUDP
distance) describes the formation/cleavage of the sugar–
phosphate bond. Finally, the third collective variable (taken
as a function of the O–HThr and HThr–OUDP distances)
measures the extent of proton transfer between the Thr
acceptor and the UDP moiety. A detailed description of the
reaction can be obtained by following the minimum free-
energy pathway on the reconstructed free-energy landscape
(see Figure S9) and examining snapshots along this pathway
(Figure 3). The Michaelis complex features a hydrogen bond
between the acceptor threonine oxygen atom and one of the
Figure 2. Dynamics of GalNAc-T2 during the catalytic cycle. A) Close-
up representation of the surface structures of GalNAc-T2 in complex
with substrates and products along the catalytic cycle. B) Proposed
ordered kinetic mechanism of GalNAc-T2.
pyrophosphate oxygen atoms. It has often been proposed, on
the basis of ternary complexes with substrate analogues[12] or
the structural superposition of complexes in which either the
sugar moiety or the acceptor is absent,[3b] that the hydrogen
atom of the acceptor hydroxy group interacts with the
leaving-group oxygen atom of the pyrophosphate moiety.
Herein we note that this hydrogen bond forms not with the
leaving-group oxygen atom but rather with one of the
nonbridging pyrophosphate oxygen atoms. This ground-state
interaction makes good chemical sense, since hydrogen bonds
are stronger when they are formed between atoms with more
closely matched pKa values. This type of configuration,
previously proposed on the basis of QM/MM calculations for
OtsA,[13] may be common in glycosyltransferases (GTs)
operating through a front-face mechanism and underscores
the value of analyzing ternary complexes to glean mechanistic
insight.
The chemical reaction starts with the elongation of the
CO bond between the UDP and the GalNAc molecule of
the donor (the C1–OUDP distance increases by almost 1 
when going from the reactants to arrangement 1 in Figure 3;
see Table S3). Simultaneously, the OThrH and NacetylH
bonds change their hydrogen-bond partners, from a nonbridg-
ing phosphate oxygen atom to the bridging oxygen atom, thus
placing the hydrogen atom at the proper position to assist the
departure of the UDP leaving group. The NacetylH···OUDP and
OThrH···OUDP hydrogen bonds not only stabilize the negative
charge being developed at the phosphate group, but they also
appropriately position the acceptor molecule to favor the
subsequent front-side nucleophilic attack. Therefore, the first
part of the reaction can be described as cleavage of the sugar–
phosphate bond, assisted by the sugar N-acetyl group,
together with the formation of a hydrogen bond between
the acceptor and the phosphate oxygen atom of the bond
being broken.
The sugar—phosphate bond is completely broken in
configuration 2 (C1—OUDP = 2.7 , Figure 3; see Table S3),
which corresponds to a minimum of the free energy landscape
(Figure S9). Remarkably, the distance between the donor and
the acceptor (C1···OThr) is still long (> 3 ), thus suggesting
the discrete formation of an oxocarbenium–phosphate ion
pair. Further evidence for the change in electronic config-
uration at the anomeric carbon atom is the shift from
a tetrahedral geometry to a trigonal geometry, which is also
associated with changes in the conformation of the pyranose
ring from a 4C1 chair in the Michaelis complex to a
4H3 half-
chair conformation in which the C2, C1, O5, and C5 atoms are
almost coplanar (1, 2, and 3 in Figure 3). This change is
accompanied by a decrease in the C1O5 bond length (from
1.38 to 1.27 ; see Table S3) and an increase in positive
charge at the anomeric center (by 0.40e when going from
the reactants to 2). Both the OThrH···OUDP and the NGalNAc
H···OUDP hydrogen bonds contribute to the stabilization of the
phosphate–oxocarbenium ion-pair intermediate (2 in
Figure 3), as well as orienting the sugar moiety for the
subsequent nucleophilic attack. Afterward, a slight displace-
ment of the GalNAc donor and acceptor molecules takes
place to facilitate the interaction between the anomeric
carbon atom and the threonine oxygen atom (configuration
3). Finally, proton transfer to the phosphate group takes place
in a process that is almost concomitant with the formation of
the sugar–peptide glycosidic bond (Figure 3, configuration 4).
The simulation shows that cleavage of the GalNAc–UDP
bond and the formation of the GalNAc–peptide bond are
entirely asynchronous and follow a stepwise pathway. The
cleavage of the GalNAc–UDP bond precedes the formation
of the GalNAc–peptide bond, and thus an intimate ion-pair
intermediate is formed, with the assistance of coordinating
hydrogen-bonding interactions between the nucleophilic
hydroxy group, the pyrophosphate leaving group, and the
N-acetyl NH moiety of the electrophilic pyranose group.
The relevance of the acetamido group in catalysis is
further supported by the substrate specificity of this family of
enzymes, which show a strong preference for UDP-GalNAc
and rarely accept UDP-galactose.[14] The overall reaction can
be regarded as “a type of internal return”, as originally
proposed by Sinnott and Jencks in their seminal report on the
solvolysis of glucose derivatives[15] by analogy with the SNi
mechanism for the decomposition of alkyl chlorosulfites.[16]
For glycosyl transfer, the names “SNi-like” and “SNi-type”
were later adopted, although the reaction has clear differ-
ences from that of alkyl chlorosulfites (the main difference
being that the nucleophile is not internal but external). The
reaction can also be termed SN1-type, since an intermediate
(although short-lived) is formed. Independently of the
Figure 3. Atomic rearrangement along the reaction pathway. Bonds
being broken/formed are drawn as transparent, whereas relevant
hydrogen bonds are represented by a dotted red line. Hydrogen atoms
have been omitted for clarity, except the acetamido NH group, and the
NH and OH groups of the acceptor threonine.
terminology adopted, the reaction mechanism of GalNAc-T2 
is consistent with a front-face attack that generates an ion-pair 
intermediate, as previously found for the retaining GT OtsA, 
as well as for glucosyl transfer in solution.[13, 17]
In summary, we have shown the formation of unprece-
dented ternary substrate and product complexes of the human 
retaining GalNAc-T2, which is an enzyme involved in 
disorders of lipid metabolism and a putative therapeutic 
target. We combined experimental data with computational 
studies to provide unique insight into structural features and 
the mechanism of this important class of isoenzymes, which 
control protein O-glycosylation. Not only do these snapshots 
explain the preference of this enzyme for acceptors contain-
ing a Thr residue and provide a detailed structural rationale 
for an ordered bi–bi kinetic mechanism, but they also show 
that this enzyme constrains reaction components to drive 
a catalytic mechanism involving front-face attack. We found 
that the reaction involves a short-lived oxocarbenium ion, 
which supports this mechanism as likely to be common for 
most retaining GTs. Finally, the uncovered catalytic mecha-
nism of GalNAc-T2 will serve as a foundation for the design 
of inhibitors that will serve as useful probe tools and might 
eventually prove therapeutically useful.
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